Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0OJ9P
|
||||
| Former ID |
DNC011054
|
||||
| Drug Name |
1-methyl-3-(phenylcarbamoyloxy)pyridinium bromide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C13H13BrN2O2
|
||||
| Canonical SMILES |
C[N+]1=CC=CC(=C1)OC(=O)NC2=CC=CC=C2.[Br-]
|
||||
| InChI |
1S/C13H12N2O2.BrH/c1-15-9-5-8-12(10-15)17-13(16)14-11-6-3-2-4-7-11;/h2-10H,1H3;1H
|
||||
| InChIKey |
WZOIYVSATGAMMK-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cholinesterase | Target Info | Inhibitor | [1] | |
| PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathway | |||||
| WikiPathways | Irinotecan Pathway | ||||
| References | |||||
| REF 1 | Long-acting anticholinesterases for myasthenia gravis: synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine. Bioorg Med Chem. 2010 Jul 1;18(13):4687-93. doi: 10.1016/j.bmc.2010.05.022. Epub 2010 May 12. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.